The Myopro orthosis is a motor-driven orthosis for hand and arm from the manufacturer Myomo. The mobile exoskeleton for the arm also supports patients who have not moved the arm or hand for years.
Everything you need to know about the features and benefits of the MyoPro: Myoelectric arm and hand orthosis from Myomo need to know.
The MyoPro Arm Prosthesis can detect weak muscle signals on the surface of the skin to activate the electric motors. This enables the patient to grasp, carry and hold again. A paralyzed or weakened musculature is supported or guided by the myoelectric orthosis system. The user is able to intuitively control the movements of the Myopro Motion via his or her body's own EMG signal.
What are the cost orthosis Myopro or the Myopro orthosis price?
A system starts at a five-digit sum. Please seek intensive advice on this.
Each MyoPro arm prosthesis is custom-made for each patient. A plaster cast of the arm is taken, which serves as the basis for the individual fabrication.
After you have successfully tested the mobile exoskeleton, you will participate in a training session with an occupational therapist to learn how to actually use it. In this way, you will be even more independent in the future. In order to support you in the best possible way, a training plan that is individually adapted to you will be developed and carried out together with you. Among other things, you will be trained how to put on and take off the orthosis, how to use it in your everyday life, and general motor coordination tasks.
No costs incurred have to be borne by the customer.
Yes! The costs are covered by German health insurance companies and accident insurance companies if they are suitable. For a final decision by the health insurance company, it is possible to carry out a longer trial of the MyoPro first. This trial is closely supervised. Trained therapists carry out special orthosis training with you, so that at the end of the trial, proof can be provided that you can use the orthosis and that it can bring you the hoped-for benefit of use.
The MyoPro makes it possible to compensate for the impaired active movement of the arm. This allows the user to regain a high degree of independence. Grasping, holding, lifting, carrying and releasing objects in a targeted manner are activities that can only be performed with both arms and can therefore be implemented again.
The Myomo MyoPro Hand-Arm Orthosis is primarily suitable for the following indications and individuals:
Group of people:
Originally developed at MIT in collaboration with Harvard Medical School and founded in 2004. Myomo has raised a total of $23.2M in 7 rounds of funding. The latest funding was raised on January 12, 2023 in a post-IPO equity round. Myomo is registered under the ticker
NYSEMKT:MYO. The company's stock opened at 7.50 $ on June 13, 2017. Myomo is funded by 2 investors. Mountain Group Capital and Boston Harbor Angels are the most recent investors.
By loading the video, you accept YouTube's privacy policy.
Learn more
Image sources: All images and graphics are copyrighted and property of ©.
2023
Myomo, Inc.
By loading the video, you accept YouTube's privacy policy.
Learn more
English 
German